TY - JOUR
T1 - IMRT with concomitant boost versus conventional radiation in the setting of sequential chemoradiotherapy for oropharyngeal cancer
AU - Franchin, Giovanni
AU - Furlan, Carlo
AU - Vaccher, Emanuela
AU - Talamini, Renato
AU - Gobitti, Carlo
AU - Grando, Giuseppe
AU - Minatel, Emilio
AU - Dassie, Andrea
AU - Trovò, Mauro Gaetano
AU - Barzan, Luigi
PY - 2013/9/4
Y1 - 2013/9/4
N2 - Objectives The aim of this study was to assess the efficacy of IMRT with concomitant boost simultaneous integrated boost-intensity modulated radiotherapy (SIB-IMRT) compared with conventional radiation in the setting of sequential chemoradiotherapy (induction chemoradiotherapy(ICRT)) for patients with advanced oropharynx cancer (OPC). Materials and methods A single-institutional retrospective review was conducted on 84 patients (conventional radiation, n = 36; SIB-IMRT, n = 48) with stage III and IV OPC, who underwent definitive ICRT from 2002 to 2012. The study endpoints included overall survival (OS) and locoregional control (LRC). Results The median follow-up of the matched cohorts resulted similar (30 months for 3D-radiation technique versus 37 months for IMRT), and baseline characteristics were generally balanced between the two groups. However, patients managed with conventional radiation were less likely to have positron emission tomography-computed tomography (PET-CT) for staging and to receive induction chemotherapy with TPF. A multivariate Cox proportional hazard model showed that OS and LRC were associated with several known prognostic factors, along with radiation modality (SIB-IMRT versus conventional radiation, hazard ratio 0·27, p = 0·004; hazard ratio 0·31, p = 0·006; for OS and LRC, respectively). Conclusions The adoption of SIB-IMRT versus conventional radiation may produce a clinical benefit in OS and LRC among patients receiving ICRT for advanced OPC.
AB - Objectives The aim of this study was to assess the efficacy of IMRT with concomitant boost simultaneous integrated boost-intensity modulated radiotherapy (SIB-IMRT) compared with conventional radiation in the setting of sequential chemoradiotherapy (induction chemoradiotherapy(ICRT)) for patients with advanced oropharynx cancer (OPC). Materials and methods A single-institutional retrospective review was conducted on 84 patients (conventional radiation, n = 36; SIB-IMRT, n = 48) with stage III and IV OPC, who underwent definitive ICRT from 2002 to 2012. The study endpoints included overall survival (OS) and locoregional control (LRC). Results The median follow-up of the matched cohorts resulted similar (30 months for 3D-radiation technique versus 37 months for IMRT), and baseline characteristics were generally balanced between the two groups. However, patients managed with conventional radiation were less likely to have positron emission tomography-computed tomography (PET-CT) for staging and to receive induction chemotherapy with TPF. A multivariate Cox proportional hazard model showed that OS and LRC were associated with several known prognostic factors, along with radiation modality (SIB-IMRT versus conventional radiation, hazard ratio 0·27, p = 0·004; hazard ratio 0·31, p = 0·006; for OS and LRC, respectively). Conclusions The adoption of SIB-IMRT versus conventional radiation may produce a clinical benefit in OS and LRC among patients receiving ICRT for advanced OPC.
KW - advanced oropharynx cancer
KW - combined modality therapy
KW - concomitant boost
KW - IMRT
KW - sequential therapy
UR - http://www.scopus.com/inward/record.url?scp=84911432984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84911432984&partnerID=8YFLogxK
U2 - 10.1017/S146039691400020X
DO - 10.1017/S146039691400020X
M3 - Article
AN - SCOPUS:84911432984
VL - 13
SP - 418
EP - 427
JO - Journal of Radiotherapy in Practice
JF - Journal of Radiotherapy in Practice
SN - 1460-3969
IS - 4
ER -